急性胰腺炎
医学
胰腺炎
重症监护医学
药品
药物输送
赔偿
药物开发
干预(咨询)
药理学
内科学
纳米技术
精神科
文学类
艺术
材料科学
作者
Xue Jiang,Yawen Zheng,Shaowen Bao,Hailin Zhang,Ruijie Chen,Qing Yao,Longfa Kou
出处
期刊:Drug Delivery
[Taylor & Francis]
日期:2020-01-01
卷期号:27 (1): 1562-1580
被引量:19
标识
DOI:10.1080/10717544.2020.1840665
摘要
Acute pancreatitis is a sudden inflammation and only last for a short time, but might lead to a life-threatening emergency. Traditional drug therapy is an essential supportive method for acute pancreatitis treatment, yet, failed to achieve satisfactory therapeutic outcomes. To date, it is still challenging to develop therapeutic medicine to redress the intricate microenvironment promptly in the inflamed pancreas, and more importantly, avoid multi-organ failure. The understanding of the acute pancreatitis, including the causes, mechanism, and severity judgment, could help the scientists bring up more effective intervention and treatment strategies. New formulation approaches have been investigated to precisely deliver therapeutics to inflammatory lesions in the pancreas, and some even could directly attenuate the pancreatic damages. In this review, we will briefly introduce the involved pathogenesis and underlying mechanisms of acute pancreatitis, as well as the traditional Chinese medicine and the new drug option. Most of all, we will summarize the drug delivery strategies to reduce inflammation and potentially prevent the further development of pancreatitis, with an emphasis on the bifunctional nanoparticles that act as both drug delivery carriers and therapeutics.
科研通智能强力驱动
Strongly Powered by AbleSci AI